Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.18 trillion and total revenue of $110.17 billion.
Market Cap
1.18T
Revenue
110.17B
Profits
-39.72B
PE Ratio
n/a
Profit Margin
-36.06%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.35B | -0.58% | 1,459,490 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.37B | -0.21% | 571,311 | 14.34B |
| 3 | ARGX | argenx SE | 52.12B | 1.51% | 262,244 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.22B | -1.77% | 799,050 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 35.48B | 3.21% | 196,137 | 5.34B |
| 6 | INSM | Insmed Incorporated | 31.67B | -4.34% | 2,229,207 | 606.42M |
| 7 | RVMD | Revolution Medicines, Inc. | 30.23B | 3.76% | 11,938,463 | - |
| 8 | RPRX | Royalty Pharma plc | 28.09B | -0.25% | 1,897,619 | 2.38B |
| 9 | BNTX | BioNTech SE | 25.15B | 1.08% | 474,969 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 21.52B | 2.69% | 4,806,889 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 21.03B | 0.93% | 3,526,734 | 13.31M |
| 12 | INCY | Incyte Corporation | 19.32B | -0.60% | 1,214,314 | 5.14B |
| 13 | GMAB | Genmab A/S | 17.83B | 0.83% | 949,889 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 16.38B | 1.29% | 3,537,877 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 15.06B | -0.30% | 1,562,921 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.93B | -3.25% | 667,718 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.69B | 0.08% | 1,288,372 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.27B | -0.86% | 658,376 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | -1.22% | 226,354 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.50B | -3.45% | 2,187,910 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.63B | -0.36% | 1,152,708 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.94B | 6.39% | 2,202,313 | 1.09B |
| 23 | ABVX | ABIVAX Société Anonyme | 9.68B | -3.43% | 985,885 | 5.37M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.47B | -1.07% | 514,411 | 7.46M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.42B | - | 540,441 | 638.50M |
| 26 | TECH | Bio-Techne Corporation | 9.15B | -0.29% | 1,500,663 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 8.70B | -3.68% | 1,076,329 | - |
| 28 | NUVL | Nuvalent, Inc. | 8.24B | -0.26% | 619,094 | - |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.06B | 1.10% | 1,164,217 | 1.40B |
| 30 | CYTK | Cytokinetics, Incorporated | 8.05B | -1.48% | 1,259,909 | 88.04M |
| 31 | IBRX | ImmunityBio, Inc. | 8.03B | 2.37% | 10,524,604 | 113.29M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.90B | -0.54% | 246,289 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.27B | -0.97% | 390,127 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.75B | 0.10% | 588,998 | 22.29M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.73B | 0.69% | 770,162 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.64B | -1.84% | 102,725 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.60B | 0.96% | 764,982 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.05% | 3,588,667 | 15.00M |
| 39 | PTCT | PTC Therapeutics, Inc. | 6.09B | 0.77% | 568,800 | 1.73B |
| 40 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.06% | 4,386,063 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.00B | 0.61% | 427,313 | 189.76M |
| 42 | CELC | Celcuity Inc. | 5.97B | 2.17% | 701,633 | - |
| 43 | CAI | Caris Life Sciences, Inc. | 5.92B | 3.76% | 1,881,282 | 812.03M |
| 44 | COGT | Cogent Biosciences, Inc. | 5.85B | -0.47% | 1,455,862 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 5.82B | -0.52% | 470,732 | 521.31M |
| 46 | CGON | CG Oncology, Inc. | 5.71B | 0.59% | 1,171,567 | 4.04M |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.67B | -0.46% | 1,263,626 | - |
| 48 | ERAS | Erasca, Inc. | 5.66B | 1.96% | 6,459,949 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.62B | -0.79% | 937,429 | 7.50M |
| 50 | IMVT | Immunovant, Inc. | 5.58B | 3.31% | 1,579,852 | - |
| 51 | CRSP | CRISPR Therapeutics AG | 5.45B | -0.18% | 1,982,307 | 3.51M |
| 52 | SYRE | Spyre Therapeutics, Inc. | 5.42B | 7.78% | 4,196,652 | - |
| 53 | APLS | Apellis Pharmaceuticals, Inc. | 5.22B | -0.01% | 2,496,824 | 1.00B |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 5.21B | 0.90% | 709,394 | 2.04M |
| 55 | TGTX | TG Therapeutics, Inc. | 5.11B | 0.12% | 1,107,209 | 616.29M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.67B | 0.50% | 840,764 | 761.41M |
| 57 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 4,927,189 | 634.21M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.49B | -3.12% | 306,521 | 268.09M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.16B | 0.05% | 739,810 | 7.70M |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.11B | -0.20% | 1,690,639 | - |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.91B | -1.25% | 742,772 | 22.50M |
| 62 | GPCR | Structure Therapeutics Inc. | 3.84B | 1.94% | 1,091,893 | - |
| 63 | LEGN | Legend Biotech Corporation | 3.80B | 9.79% | 2,859,322 | 1.03B |
| 64 | TVTX | Travere Therapeutics, Inc. | 3.78B | -2.80% | 4,523,081 | 490.73M |
| 65 | ACAD | ACADIA Pharmaceuticals Inc. | 3.71B | -1.18% | 1,232,954 | 1.07B |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.64B | -0.37% | 321,853 | 803.79M |
| 67 | EWTX | Edgewise Therapeutics, Inc. | 3.62B | 1.63% | 1,242,902 | - |
| 68 | TNGX | Tango Therapeutics, Inc. | 3.61B | 5.28% | 4,398,877 | 62.38M |
| 69 | DNLI | Denali Therapeutics Inc. | 3.44B | 7.54% | 1,877,465 | - |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.30B | 0.86% | 2,629,763 | - |
| 71 | ORKA | Oruka Therapeutics, Inc. | 3.25B | -2.25% | 1,402,998 | - |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.16B | -1.30% | 881,057 | 588.99M |
| 73 | VERA | Vera Therapeutics, Inc. | 3.12B | -2.05% | 1,321,736 | - |
| 74 | ALMS | Alumis Inc. | 3.07B | 5.55% | 1,254,452 | 24.05M |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 3.06B | -2.72% | 188,335 | 451.36M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | -2.03% | 775,533 | 376.07M |
| 77 | BEAM | Beam Therapeutics Inc. | 3.05B | 1.25% | 1,847,557 | 139.74M |
| 78 | MANE | Veradermics, Incorporated | 3.01B | 7.35% | 545,712 | - |
| 79 | RCUS | Arcus Biosciences, Inc. | 2.97B | 3.00% | 1,047,611 | 247.00M |
| 80 | IDYA | IDEAYA Biosciences, Inc. | 2.83B | -0.53% | 2,158,381 | 218.71M |
| 81 | RLAY | Relay Therapeutics, Inc. | 2.77B | 5.02% | 3,872,244 | 15.36M |
| 82 | SLNO | Soleno Therapeutics, Inc. | 2.72B | -0.10% | 5,203,719 | 190.41M |
| 83 | IRON | Disc Medicine, Inc. | 2.68B | -0.43% | 300,163 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.66B | 1.62% | 971,669 | 1.55M |
| 85 | IMNM | Immunome, Inc. | 2.65B | 2.14% | 648,919 | 6.94M |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.63B | -2.01% | 865,775 | - |
| 87 | ZLAB | Zai Lab Limited | 2.62B | 5.87% | 1,401,882 | 460.16M |
| 88 | KOD | Kodiak Sciences Inc. | 2.59B | -6.86% | 732,421 | - |
| 89 | ADMA | ADMA Biologics, Inc. | 2.54B | 1.53% | 4,357,993 | 510.17M |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.51B | 11.35% | 3,181,661 | - |
| 91 | AAPG | Ascentage Pharma Group International | 2.49B | 5.45% | 2,041 | 82.08M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.47B | 2.48% | 1,943,961 | 673.00M |
| 93 | NKTR | Nektar Therapeutics | 2.39B | 2.41% | 532,557 | 55.23M |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 2.28B | -1.90% | 2,135,893 | 2.20B |
| 95 | ADPT | Adaptive Biotechnologies Corporation | 2.24B | - | 949,024 | 276.98M |
| 96 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.05% | 1,026,597 | 158.18M |
| 97 | DFTX | Definium Therapeutics, Inc. | 2.21B | 1.00% | 1,501,640 | - |
| 98 | SNDX | Syndax Pharmaceuticals, Inc. | 2.15B | -0.41% | 1,464,619 | 172.35M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | -0.12% | 867,906 | 283.06M |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.10B | -0.89% | 309,847 | 184.42M |
| 101 | ZYME | Zymeworks Inc. | 2.05B | 2.78% | 790,520 | 105.97M |
| 102 | SION | Sionna Therapeutics, Inc. | 2.03B | 4.13% | 768,535 | - |
| 103 | AGIO | Agios Pharmaceuticals, Inc. | 2.02B | 3.45% | 572,158 | 54.03M |
| 104 | CAPR | Capricor Therapeutics, Inc. | 2.02B | 0.92% | 757,050 | 11.13M |
| 105 | MESO | Mesoblast Limited | 2.01B | 7.80% | 315,724 | 65.38M |
| 106 | RXRX | Recursion Pharmaceuticals, Inc. | 1.98B | 5.93% | 12,882,920 | 74.68M |
| 107 | ANAB | AnaptysBio, Inc. | 1.95B | -3.32% | 232,664 | 234.60M |
| 108 | OCUL | Ocular Therapeutix, Inc. | 1.94B | 1.71% | 2,555,104 | 51.95M |
| 109 | GLPG | Galapagos NV | 1.91B | 0.97% | 131,126 | 1.31B |
| 110 | PHVS | Pharvaris N.V. | 1.91B | 1.60% | 89,961 | - |
| 111 | TYRA | Tyra Biosciences, Inc. | 1.88B | -0.85% | 1,062,047 | - |
| 112 | PVLA | Palvella Therapeutics, Inc. | 1.84B | -0.69% | 165,303 | - |
| 113 | TRVI | Trevi Therapeutics, Inc. | 1.83B | 1.64% | 743,690 | - |
| 114 | VCEL | Vericel Corporation | 1.80B | 0.65% | 364,326 | 276.26M |
| 115 | INVA | Innoviva, Inc. | 1.77B | -1.12% | 515,379 | 411.33M |
| 116 | NTLA | Intellia Therapeutics, Inc. | 1.76B | 1.08% | 2,708,786 | 67.67M |
| 117 | NRIX | Nurix Therapeutics, Inc. | 1.75B | 4.11% | 1,679,110 | 71.78M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.75B | 1.55% | 207,637 | - |
| 119 | TSHA | Taysha Gene Therapies, Inc. | 1.72B | 27.39% | 9,836,582 | 9.77M |
| 120 | HRMY | Harmony Biosciences Holdings, Inc. | 1.69B | -0.24% | 549,991 | 868.45M |
| 121 | VIR | Vir Biotechnology, Inc. | 1.67B | 4.08% | 2,238,446 | 68.56M |
| 122 | NUVB | Nuvation Bio Inc. | 1.65B | -0.62% | 1,821,270 | 62.90M |
| 123 | OCS | Oculis Holding AG | 1.63B | -0.22% | 147,406 | 1.51M |
| 124 | NBTX | Nanobiotix S.A. | 1.61B | 4.30% | 68,263 | 38.27M |
| 125 | DMRA | Damora Therapeutics, Inc. | 1.60B | -0.45% | 293,203 | - |
| 126 | IMCR | Immunocore Holdings plc | 1.60B | -0.16% | 142,811 | 400.02M |
| 127 | GENB | Generate Biomedicines, Inc. | 1.59B | -3.03% | 411,303 | 31.89M |
| 128 | IOVA | Iovance Biotherapeutics, Inc. | 1.57B | 4.95% | 12,235,418 | 263.50M |
| 129 | MBX | MBX Biosciences, Inc. | 1.57B | 0.46% | 317,866 | - |
| 130 | BHVN | Biohaven Ltd. | 1.56B | -0.67% | 1,960,864 | - |
| 131 | BCAX | Bicara Therapeutics Inc. | 1.55B | 3.22% | 736,825 | - |
| 132 | ARDX | Ardelyx, Inc. | 1.55B | -0.47% | 3,432,293 | 407.32M |
| 133 | VRDN | Viridian Therapeutics, Inc. | 1.52B | -2.04% | 1,367,907 | 70.85M |
| 134 | SVRA | Savara Inc. | 1.49B | -3.29% | 1,133,735 | - |
| 135 | IMTX | Immatics N.V. | 1.48B | 0.46% | 322,180 | 56.67M |
| 136 | ATAI | AtaiBeckley Inc. | 1.46B | 3.90% | 3,334,662 | 4.09M |
| 137 | GLUE | Monte Rosa Therapeutics, Inc. | 1.46B | 4.17% | 944,198 | 123.67M |
| 138 | OLMA | Olema Pharmaceuticals, Inc. | 1.44B | 1.17% | 678,623 | - |
| 139 | WVE | Wave Life Sciences Ltd. | 1.43B | 2.71% | 3,461,445 | 42.73M |
| 140 | NVAX | Novavax, Inc. | 1.42B | 3.58% | 2,962,275 | 1.12B |
| 141 | PGEN | Precigen, Inc. | 1.38B | -2.01% | 2,671,798 | 9.68M |
| 142 | MAZE | Maze Therapeutics, Inc. | 1.33B | -3.00% | 861,323 | 2.50M |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.30B | 6.40% | 594,487 | - |
| 144 | MLTX | MoonLake Immunotherapeutics | 1.29B | -4.05% | 1,077,293 | - |
| 145 | PHAR | Pharming Group N.V. | 1.27B | 0.68% | 4,129 | 376.13M |
| 146 | DBVT | DBV Technologies S.A. | 1.27B | -1.80% | 193,183 | 5.64M |
| 147 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | -0.92% | 961,882 | - |
| 148 | ZBIO | Zenas BioPharma, Inc. | 1.25B | -1.36% | 631,253 | 10.00M |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.22B | 0.49% | 263,857 | 1.30M |
| 150 | EYPT | EyePoint, Inc. | 1.22B | 2.02% | 590,040 | 31.37M |
| 151 | MPLT | MapLight Therapeutics, Inc. | 1.18B | -0.44% | 181,270 | - |
| 152 | ABCL | AbCellera Biologics Inc. | 1.17B | 2.66% | 3,012,264 | 75.13M |
| 153 | SEPN | Septerna, Inc. | 1.16B | 7.46% | 816,060 | 45.95M |
| 154 | IVA | Inventiva S.A. | 1.13B | 4.17% | 653,636 | 9.31M |
| 155 | GERN | Geron Corporation | 1.08B | -4.52% | 21,002,984 | 183.88M |
| 156 | QURE | uniQure N.V. | 1.08B | 0.94% | 1,456,346 | 16.10M |
| 157 | XERS | Xeris Biopharma Holdings, Inc. | 1.07B | 2.14% | 1,037,658 | 291.85M |
| 158 | KALV | KalVista Pharmaceuticals, Inc. | 1.07B | 2.81% | 889,379 | 73.62M |
| 159 | GHRS | GH Research PLC | 1.05B | 1.37% | 69,657 | - |
| 160 | CMPX | Compass Therapeutics, Inc. | 1.05B | 7.54% | 3,192,236 | 850.00K |
| 161 | URGN | UroGen Pharma Ltd. | 1.05B | 1.37% | 816,550 | 109.79M |
| 162 | ORIC | ORIC Pharmaceuticals, Inc. | 1.03B | -2.37% | 1,775,702 | - |
| 163 | ANNX | Annexon, Inc. | 1.02B | 9.48% | 4,342,087 | - |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 1.02B | 0.95% | 502,177 | 175.11M |
| 165 | AKTS | Aktis Oncology, Inc. | 999.94M | 1.40% | 150,331 | 6.50M |
| 166 | CTMX | CytomX Therapeutics, Inc. | 985.77M | 0.44% | 4,731,695 | 76.20M |
| 167 | EVMN | Evommune, Inc. | 970.33M | 1.16% | 181,139 | 13.00M |
| 168 | JBIO | Jade Biosciences, Inc. | 949.83M | -0.93% | 289,457 | - |
| 169 | FTRE | Fortrea Holdings Inc. | 939.68M | 4.80% | 1,196,304 | 2.72B |
| 170 | SANA | Sana Biotechnology, Inc. | 918.02M | -1.15% | 4,278,086 | - |
| 171 | XNCR | Xencor, Inc. | 917.47M | - | 978,365 | 125.58M |
| 172 | MGTX | MeiraGTx Holdings plc | 916.27M | -0.35% | 711,492 | 81.39M |
| 173 | JANX | Janux Therapeutics, Inc. | 914.91M | -1.31% | 987,634 | 10.00M |
| 174 | CGEM | Cullinan Therapeutics, Inc. | 904.87M | 4.18% | 977,903 | - |
| 175 | MRVI | Maravai LifeSciences Holdings, Inc. | 899.74M | 6.71% | 1,751,124 | 185.74M |
| 176 | OMER | Omeros Corporation | 881.95M | 3.46% | 1,159,429 | - |
| 177 | SLS | SELLAS Life Sciences Group, Inc. | 881.75M | 1.03% | 2,670,213 | - |
| 178 | ABUS | Arbutus Biopharma Corporation | 875.74M | 2.99% | 3,280,160 | 14.08M |
| 179 | DRUG | Bright Minds Biosciences Inc. | 869.15M | 0.54% | 107,491 | - |
| 180 | TBPH | Theravance Biopharma, Inc. | 856.84M | 0.24% | 349,322 | 107.46M |
| 181 | MNKD | MannKind Corporation | 855.36M | 1.09% | 3,212,573 | 348.97M |
| 182 | VOR | Vor Biopharma Inc. | 845.30M | -1.70% | 881,953 | - |
| 183 | SGP | SpyGlass Pharma, Inc. | 826.64M | 0.86% | 28,129 | - |
| 184 | SLDB | Solid Biosciences Inc. | 818.62M | 1.09% | 933,990 | - |
| 185 | ANRO | Alto Neuroscience, Inc. | 813.65M | -1.36% | 341,362 | - |
| 186 | KURA | Kura Oncology, Inc. | 799.38M | -0.98% | 874,517 | 67.48M |
| 187 | SPRY | ARS Pharmaceuticals, Inc. | 796.36M | -1.47% | 1,593,730 | 84.28M |
| 188 | LXRX | Lexicon Pharmaceuticals, Inc. | 788.05M | 6.29% | 2,135,663 | 49.80M |
| 189 | DSGN | Design Therapeutics, Inc. | 786.32M | 0.87% | 428,277 | - |
| 190 | FBRX | Forte Biosciences, Inc. | 765.68M | -3.52% | 214,412 | - |
| 191 | RLMD | Relmada Therapeutics, Inc. | 753.10M | -0.14% | 1,268,444 | - |
| 192 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 751.51M | 2.29% | 535,985 | - |
| 193 | LBRX | LB Pharmaceuticals Inc | 736.71M | 9.60% | 744,564 | - |
| 194 | GYRE | Gyre Therapeutics, Inc. | 732.34M | 2.30% | 62,413 | 116.59M |
| 195 | TENX | Tenax Therapeutics, Inc. | 704.71M | -5.21% | 614,880 | - |
| 196 | ARVN | Arvinas, Inc. | 701.65M | -0.27% | 607,060 | 262.60M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 693.52M | 0.64% | 271,631 | - |
| 198 | PRME | Prime Medicine, Inc. | 671.13M | 2.43% | 2,174,107 | 4.63M |
| 199 | CBIO | Crescent Biopharma, Inc. | 662.62M | 2.20% | 229,311 | 10.84M |
| 200 | OCGN | Ocugen, Inc. | 658.90M | 8.33% | 5,999,559 | 4.41M |
| 201 | PROK | ProKidney Corp. | 606.85M | 5.24% | 2,818,716 | 893.00K |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 605.90M | 5.41% | 732,110 | 106.47M |
| 203 | RIGL | Rigel Pharmaceuticals, Inc. | 592.25M | 2.13% | 382,281 | 294.28M |
| 204 | EIKN | Eikon Therapeutics, Inc. | 586.86M | 2.17% | 311,859 | - |
| 205 | PRTA | Prothena Corporation plc | 582.47M | 1.98% | 409,928 | 9.68M |
| 206 | MDXG | MiMedx Group, Inc. | 576.44M | -1.02% | 1,063,023 | 418.63M |
| 207 | CRMD | CorMedix Inc. | 571.53M | -0.96% | 1,079,584 | 311.71M |
| 208 | KYTX | Kyverna Therapeutics, Inc. | 568.28M | 0.43% | 600,686 | - |
| 209 | TECX | Tectonic Therapeutic, Inc. | 557.48M | -0.87% | 169,348 | - |
| 210 | LYEL | Lyell Immunopharma, Inc. | 556.15M | 2.01% | 86,967 | 36.00K |
| 211 | VSTM | Verastem, Inc. | 556.05M | 3.09% | 2,016,996 | 30.91M |
| 212 | ADCT | ADC Therapeutics SA | 555.18M | 13.21% | 2,733,498 | 81.36M |
| 213 | FULC | Fulcrum Therapeutics, Inc. | 549.45M | 4.43% | 705,833 | 80.00M |
| 214 | ACRS | Aclaris Therapeutics, Inc. | 546.25M | 0.26% | 1,255,058 | 7.83M |
| 215 | STTK | Shattuck Labs, Inc. | 541.92M | 5.75% | 342,810 | 1.00M |
| 216 | ZURA | Zura Bio Limited | 539.87M | -0.52% | 478,950 | - |
| 217 | UPB | Upstream Bio, Inc. | 537.67M | -4.45% | 552,409 | 2.85M |
| 218 | VALN | Valneva SE | 536.99M | -0.99% | 87,267 | 205.07M |
| 219 | IMMX | Immix Biopharma, Inc. | 532.24M | 1.93% | 617,420 | - |
| 220 | ALLO | Allogene Therapeutics, Inc. | 529.00M | -4.82% | 74,135,392 | 22.00K |
| 221 | ENGN | enGene Therapeutics Inc. | 519.84M | 2.11% | 211,275 | - |
| 222 | AGMB | AgomAb Therapeutics NV | 519.53M | 1.81% | 213,755 | - |
| 223 | LXEO | Lexeo Therapeutics, Inc. | 503.79M | 1.95% | 608,689 | - |
| 224 | TRDA | Entrada Therapeutics, Inc. | 503.64M | -0.29% | 79,158 | 25.42M |
| 225 | LRMR | Larimar Therapeutics, Inc. | 501.75M | -0.82% | 1,766,999 | - |
| 226 | FDMT | 4D Molecular Therapeutics, Inc. | 498.77M | 1.14% | 685,023 | 85.21M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 494.70M | 2.16% | 1,154,066 | - |
| 228 | STRO | Sutro Biopharma, Inc. | 493.21M | 3.44% | 315,567 | 102.48M |
| 229 | ANL | Adlai Nortye Ltd. | 488.93M | -15.50% | 1,112,488 | 5.40M |
| 230 | ABSI | Absci Corporation | 485.08M | 0.63% | 2,820,277 | 2.80M |
| 231 | IVVD | Invivyd, Inc. | 483.59M | 6.21% | 1,634,319 | 53.43M |
| 232 | RGNX | REGENXBIO Inc. | 483.14M | 0.65% | 651,848 | 170.44M |
| 233 | XOMA | XOMA Royalty Corporation | 478.18M | 1.83% | 176,743 | 52.15M |
| 234 | ASMB | Assembly Biosciences, Inc. | 472.87M | 1.26% | 62,139 | 72.30M |
| 235 | AVIR | Atea Pharmaceuticals, Inc. | 468.47M | 1.38% | 244,244 | - |
| 236 | VTVT | vTv Therapeutics Inc. | 468.09M | -1.59% | 38,648 | 17.00K |
| 237 | BNTC | Benitec Biopharma Inc. | 465.87M | 2.64% | 175,909 | - |
| 238 | IPSC | Century Therapeutics, Inc. | 465.48M | 9.28% | 1,591,080 | 109.16M |
| 239 | PRLD | Prelude Therapeutics Incorporated | 455.59M | 25.45% | 978,037 | 12.14M |
| 240 | AURA | Aura Biosciences, Inc. | 454.83M | - | 325,568 | - |
| 241 | DNA | Ginkgo Bioworks Holdings, Inc. | 453.43M | 0.91% | 831,333 | 170.16M |
| 242 | EPRX | Eupraxia Pharmaceuticals Inc. | 449.03M | 2.49% | 57,842 | - |
| 243 | ALT | Altimmune, Inc. | 442.36M | 3.34% | 2,080,064 | 41.00K |
| 244 | ARMP | Armata Pharmaceuticals, Inc. | 441.79M | -6.37% | 28,780 | 4.90M |
| 245 | PRTC | PureTech Health plc | 440.86M | 2.13% | 3,250 | 6.39M |
| 246 | VNDA | Vanda Pharmaceuticals Inc. | 429.72M | -0.68% | 862,204 | 216.11M |
| 247 | RCKT | Rocket Pharmaceuticals, Inc. | 423.40M | 6.59% | 2,522,365 | - |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 422.23M | -0.55% | 108,441 | 66.98M |
| 249 | CLYM | Climb Bio, Inc. | 413.19M | -2.26% | 830,191 | - |
| 250 | NAUT | Nautilus Biotechnology, Inc. | 411.33M | 6.21% | 281,026 | - |
| 251 | IRD | Opus Genetics, Inc. | 406.26M | 2.88% | 696,340 | 14.20M |
| 252 | LCTX | Lineage Cell Therapeutics, Inc. | 406.01M | 2.52% | 1,803,616 | 14.56M |
| 253 | AUTL | Autolus Therapeutics plc | 396.55M | 0.68% | 1,267,122 | 75.39M |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 393.68M | 3.10% | 436,706 | 35.11M |
| 255 | PALI | Palisade Bio, Inc. | 391.77M | 13.59% | 5,905,544 | - |
| 256 | MNPR | Monopar Therapeutics Inc. | 387.54M | -0.02% | 145,301 | - |
| 257 | YDES | YD Bio Limited | 382.19M | -4.65% | 31,614 | 510.36K |
| 258 | PBYI | Puma Biotechnology, Inc. | 380.56M | -1.19% | 262,822 | 228.37M |
| 259 | NAGE | Niagen Bioscience, Inc. | 380.37M | 1.07% | 1,005,343 | 129.42M |
| 260 | ZNTL | Zentalis Pharmaceuticals, Inc. | 380.19M | 3.08% | 2,562,549 | 26.87M |
| 261 | CABA | Cabaletta Bio, Inc. | 378.50M | 4.29% | 2,137,659 | - |
| 262 | CADL | Candel Therapeutics, Inc. | 377.22M | 0.98% | 1,011,274 | - |
| 263 | NMRA | Neumora Therapeutics, Inc. | 375.00M | 1.48% | 1,103,233 | - |
| 264 | NGNE | Neurogene Inc. | 373.78M | 15.61% | 370,104 | 925.00K |
| 265 | RZLT | Rezolute, Inc. | 372.90M | 1.13% | 1,007,495 | - |
| 266 | IMRX | Immuneering Corporation | 371.75M | 6.28% | 894,588 | - |
| 267 | BCYC | Bicycle Therapeutics plc | 368.05M | 4.35% | 620,740 | 72.59M |
| 268 | SRZN | Surrozen, Inc. | 367.80M | 0.53% | 286,369 | 3.48M |
| 269 | OVID | Ovid Therapeutics Inc. | 363.97M | -6.76% | 3,987,102 | 7.25M |
| 270 | GLSI | Greenwich LifeSciences, Inc. | 358.97M | -0.42% | 81,266 | - |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 354.55M | 0.61% | 124,235 | - |
| 272 | SLN | Silence Therapeutics plc | 343.86M | 18.95% | 619,033 | 559.00K |
| 273 | NGEN | NervGen Pharma Corp. | 343.15M | 1.19% | 343,833 | - |
| 274 | EDIT | Editas Medicine, Inc. | 329.83M | -0.59% | 1,570,093 | 40.52M |
| 275 | ACIU | AC Immune SA | 311.49M | -1.57% | 214,644 | 4.51M |
| 276 | ABEO | Abeona Therapeutics Inc. | 308.06M | 4.05% | 907,191 | 5.82M |
| 277 | PLYX | Polaryx Therapeutics, Inc. | 305.84M | -0.15% | 86,370 | - |
| 278 | IKT | Inhibikase Therapeutics, Inc. | 305.06M | 5.29% | 1,096,988 | 1.00 |
| 279 | CLLS | Cellectis S.A. | 304.73M | -1.68% | 18,377 | 79.59M |
| 280 | AVTX | Avalo Therapeutics, Inc. | 304.23M | -3.96% | 498,425 | 59.00K |
| 281 | NBP | NovaBridge Biosciences | 300.69M | 2.36% | 745,644 | - |
| 282 | LENZ | LENZ Therapeutics, Inc. | 300.38M | -3.23% | 958,394 | 19.09M |
| 283 | AVXL | Anavex Life Sciences Corp. | 300.26M | 3.85% | 993,762 | - |
| 284 | CHRS | Coherus Oncology, Inc. | 289.93M | 4.44% | 1,069,962 | 42.17M |
| 285 | FHTX | Foghorn Therapeutics Inc. | 285.87M | 0.41% | 137,428 | 30.91M |
| 286 | ALEC | Alector, Inc. | 284.74M | 7.05% | 538,356 | 21.05M |
| 287 | SABS | SAB Biotherapeutics, Inc. | 284.62M | 4.92% | 880,896 | 114.70K |
| 288 | CCCC | C4 Therapeutics, Inc. | 282.00M | 4.71% | 1,854,838 | 35.95M |
| 289 | TARA | Protara Therapeutics, Inc. | 281.78M | 1.56% | 424,864 | - |
| 290 | HELP | Cybin Inc. | 275.20M | 0.73% | 445,146 | - |
| 291 | CGEN | Compugen Ltd. | 273.26M | 0.35% | 672,745 | 72.76M |
| 292 | MIST | Milestone Pharmaceuticals Inc. | 269.83M | 8.37% | 3,686,547 | 1.55M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 267.44M | 1.33% | 102,804 | 33.48M |
| 294 | NERV | Minerva Neurosciences, Inc. | 267.44M | 5.28% | 294,681 | - |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 260.87M | 4.31% | 103,665 | 19.39M |
| 296 | ADAG | Adagene Inc. | 252.40M | 0.26% | 362,937 | 7.67M |
| 297 | ELDN | Eledon Pharmaceuticals, Inc. | 250.69M | 3.12% | 2,138,988 | - |
| 298 | ARCT | Arcturus Therapeutics Holdings Inc. | 245.01M | -0.69% | 390,670 | 82.03M |
| 299 | VYGR | Voyager Therapeutics, Inc. | 240.19M | 2.28% | 869,002 | 40.37M |
| 300 | CAMP | Camp4 Therapeutics Corporation | 238.31M | 1.55% | 157,129 | 3.50M |
| 301 | KROS | Keros Therapeutics, Inc. | 230.89M | 1.39% | 305,229 | 244.06M |
| 302 | CNTX | Context Therapeutics Inc. | 230.62M | - | 936,784 | - |
| 303 | NVCT | Nuvectis Pharma, Inc. | 225.18M | -2.63% | 49,823 | - |
| 304 | ARTV | Artiva Biotherapeutics, Inc. | 224.92M | 21.50% | 877,846 | 251.00K |
| 305 | FENC | Fennec Pharmaceuticals Inc. | 224.09M | 4.00% | 163,145 | 44.64M |
| 306 | MGNX | MacroGenics, Inc. | 223.73M | 0.86% | 649,848 | 149.50M |
| 307 | CDXS | Codexis, Inc. | 223.54M | 3.80% | 1,264,856 | 70.39M |
| 308 | MDWD | MediWound Ltd. | 221.70M | -2.54% | 74,323 | 16.96M |
| 309 | ALXO | ALX Oncology Holdings Inc. | 221.10M | 4.02% | 1,138,430 | - |
| 310 | ELTX | Elicio Therapeutics, Inc. | 216.71M | 0.43% | 75,964 | - |
| 311 | OABI | OmniAb, Inc. | 214.28M | 1.37% | 672,829 | 18.67M |
| 312 | CRBU | Caribou Biosciences, Inc. | 212.60M | 3.77% | 1,957,287 | 11.16M |
| 313 | PRQR | ProQR Therapeutics N.V. | 209.67M | - | 532,111 | 19.19M |
| 314 | TNXP | Tonix Pharmaceuticals Holding Corp. | 203.71M | 7.42% | 661,163 | 13.11M |
| 315 | CNTN | Canton Strategic Holdings, Inc. | 202.83M | 5.60% | 898,205 | - |
| 316 | MENS | Jyong Biotech Ltd. | 202.25M | -1.50% | 172,391 | - |
| 317 | SGMT | Sagimet Biosciences Inc. | 197.79M | 9.57% | 521,400 | - |
| 318 | DTIL | Precision BioSciences, Inc. | 197.65M | 5.95% | 297,694 | 34.26M |
| 319 | KRRO | Korro Bio, Inc. | 197.30M | -1.79% | 77,439 | 6.39M |
| 320 | ABOS | Acumen Pharmaceuticals, Inc. | 196.42M | 1.49% | 347,868 | - |
| 321 | HURA | TuHURA Biosciences, Inc. | 195.19M | -2.54% | 1,856,718 | - |
| 322 | ENLV | Enlivex Ltd. | 194.65M | 0.49% | 345,751 | - |
| 323 | KPTI | Karyopharm Therapeutics Inc. | 192.97M | 1.30% | 348,031 | 146.07M |
| 324 | PLX | Protalix BioTherapeutics, Inc. | 191.76M | 0.85% | 682,511 | 52.74M |
| 325 | ACHV | Achieve Life Sciences, Inc. | 189.00M | -1.66% | 2,133,218 | - |
| 326 | REPL | Replimune Group, Inc. | 188.27M | 16.92% | 12,776,641 | - |
| 327 | AGEN | Agenus Inc. | 185.46M | 2.33% | 1,475,827 | 114.20M |
| 328 | WHWK | Whitehawk Therapeutics, Inc. | 184.07M | -2.50% | 316,497 | 7.15M |
| 329 | HRTX | Heron Therapeutics, Inc. | 180.37M | 2.09% | 1,661,037 | 154.90M |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 177.36M | -0.20% | 225,917 | - |
| 331 | UNCY | Unicycive Therapeutics, Inc. | 175.91M | 0.43% | 452,788 | - |
| 332 | NKTX | Nkarta, Inc. | 172.52M | 5.68% | 762,229 | - |
| 333 | TLSA | Tiziana Life Sciences Ltd | 169.74M | 3.10% | 141,206 | - |
| 334 | GALT | Galectin Therapeutics Inc. | 168.52M | 3.64% | 309,406 | - |
| 335 | TNYA | Tenaya Therapeutics, Inc. | 167.09M | 4.19% | 2,788,689 | - |
| 336 | CNTB | Connect Biopharma Holdings Limited | 165.61M | -3.93% | 248,634 | 64.00K |
| 337 | BDTX | Black Diamond Therapeutics, Inc. | 164.42M | 7.89% | 805,112 | 70.00M |
| 338 | HUMA | Humacyte, Inc. | 163.43M | 6.51% | 4,428,757 | 2.04M |
| 339 | RNAC | Cartesian Therapeutics, Inc. | 158.79M | -5.67% | 195,416 | 2.80M |
| 340 | MOLN | Molecular Partners AG | 158.05M | 1.45% | 1,091 | 856.30K |
| 341 | IPHA | Innate Pharma S.A. | 156.11M | 3.68% | 11,945 | 10.57M |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 154.50M | 0.53% | 103,860 | 2.00M |
| 343 | SPRO | Spero Therapeutics, Inc. | 152.83M | -5.04% | 696,141 | 66.80M |
| 344 | FATE | Fate Therapeutics, Inc. | 149.98M | -3.73% | 1,423,335 | 6.65M |
| 345 | ACOG | Alpha Cognition Inc. | 146.98M | 4.01% | 85,666 | 10.22M |
| 346 | IMUX | Immunic, Inc. | 144.82M | -5.93% | 3,547,640 | - |
| 347 | BMEA | Biomea Fusion, Inc. | 142.43M | 1.03% | 1,213,557 | - |
| 348 | KLRS | Kalaris Therapeutics, Inc. | 134.59M | 0.86% | 166,328 | - |
| 349 | EQ | Equillium, Inc. | 129.61M | 6.77% | 646,926 | 4.39M |
| 350 | ONCY | Oncolytics Biotech Inc. | 127.74M | 7.84% | 1,269,362 | - |
| 351 | GNLX | Genelux Corporation | 126.02M | 7.58% | 404,324 | 8.00K |
| 352 | NTHI | NeOnc Technologies Holdings, Inc. | 122.84M | -4.27% | 31,988 | 39.99K |
| 353 | PEPG | PepGen Inc. | 118.88M | 1.78% | 3,596,350 | - |
| 354 | ANTX | AN2 Therapeutics, Inc. | 117.31M | 9.40% | 1,050,566 | - |
| 355 | CRDF | Cardiff Oncology, Inc. | 116.22M | 4.29% | 1,074,611 | 593.00K |
| 356 | KZIA | Kazia Therapeutics Limited | 114.27M | 5.71% | 530,068 | 1.27M |
| 357 | SGMO | Sangamo Therapeutics, Inc. | 113.97M | 7.54% | 6,796,074 | 39.55M |
| 358 | AARD | Aardvark Therapeutics, Inc. | 110.83M | 9.48% | 287,211 | - |
| 359 | SEER | Seer, Inc. | 110.58M | 1.03% | 358,219 | 16.58M |
| 360 | PMN | ProMIS Neurosciences, Inc. | 110.30M | 2.07% | 30,649 | - |
| 361 | ALDX | Aldeyra Therapeutics, Inc. | 110.13M | 2.23% | 1,825,262 | - |
| 362 | CBUS | Cibus, Inc. | 109.69M | 1.41% | 556,913 | 3.64M |
| 363 | PYXS | Pyxis Oncology, Inc. | 107.44M | 0.59% | 334,653 | 13.86M |
| 364 | COYA | Coya Therapeutics, Inc. | 106.26M | 1.57% | 107,171 | 7.95M |
| 365 | GOSS | Gossamer Bio, Inc. | 105.82M | 4.47% | 8,782,765 | 48.47M |
| 366 | TTRX | Turn Therapeutics Inc. | 102.17M | 1.48% | 41,726 | - |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 101.53M | 3.32% | 59,979 | 35.58M |
| 368 | ANIX | Anixa Biosciences, Inc. | 98.24M | 1.74% | 93,096 | - |
| 369 | INO | Inovio Pharmaceuticals, Inc. | 97.51M | 7.21% | 7,276,027 | 65.34K |
| 370 | CGTX | Cognition Therapeutics, Inc. | 97.40M | 11.75% | 1,073,737 | - |
| 371 | VANI | Vivani Medical, Inc. | 96.50M | 6.54% | 247,066 | - |
| 372 | RANI | Rani Therapeutics Holdings, Inc. | 95.73M | 14.65% | 1,023,625 | 1.63M |
| 373 | SPRB | Spruce Biosciences, Inc. | 95.13M | 2.24% | 54,644 | 697.00K |
| 374 | EXOZ | eXoZymes, Inc. | 91.91M | -1.45% | 9,667 | -700.00 |
| 375 | GANX | Gain Therapeutics, Inc. | 90.40M | 13.23% | 788,131 | - |
| 376 | PYPD | PolyPid Ltd. | 90.07M | 6.79% | 89,519 | - |
| 377 | QTTB | Q32 Bio Inc. | 89.09M | 3.57% | 239,215 | 53.74M |
| 378 | LONA | LeonaBio, Inc. | 89.05M | 4.52% | 33,424 | - |
| 379 | IFRX | InflaRx N.V. | 87.47M | 6.14% | 1,200,641 | 34.44K |
| 380 | OKYO | OKYO Pharma Limited | 86.59M | 4.43% | 81,061 | - |
| 381 | MAIA | MAIA Biotechnology, Inc. | 86.15M | 3.65% | 800,060 | - |
| 382 | CSBR | Champions Oncology, Inc. | 85.82M | 7.85% | 6,065 | 57.95M |
| 383 | GUTS | Fractyl Health, Inc. | 85.67M | 6.15% | 1,511,651 | 3.00K |
| 384 | ACET | Adicet Bio, Inc. | 85.13M | 13.14% | 346,155 | - |
| 385 | MCRB | Seres Therapeutics, Inc. | 84.74M | 2.67% | 42,456 | 789.00K |
| 386 | NRXP | NRx Pharmaceuticals, Inc. | 83.25M | 0.80% | 1,081,602 | 1.23M |
| 387 | ATYR | aTyr Pharma, Inc. | 82.63M | 0.21% | 1,058,545 | 190.00K |
| 388 | PLRX | Pliant Therapeutics, Inc. | 81.11M | 0.77% | 123,595 | - |
| 389 | COEP | Coeptis Therapeutics Holdings, Inc. | 80.84M | 4.42% | 20,787 | 1.36M |
| 390 | NRXS | NeurAxis, Inc. | 78.31M | -2.51% | 79,550 | 3.57M |
| 391 | FBIO | Fortress Biotech, Inc. | 78.25M | 0.41% | 370,678 | 63.26M |
| 392 | FLNA | Filana Therapeutics, Inc. | 77.78M | 1.26% | 384,270 | - |
| 393 | PTHS | Pelthos Therapeutics Inc. | 77.18M | - | 27,915 | 16.80M |
| 394 | IMMP | Immutep Limited | 76.01M | 72.81% | 704,456,734 | 5.28M |
| 395 | PDSB | PDS Biotechnology Corporation | 75.91M | 28.30% | 3,834,743 | - |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 75.19M | -4.08% | 473,455 | - |
| 397 | XBIT | XBiotech Inc. | 75.00M | 1.23% | 6,391 | - |
| 398 | ESLA | Estrella Immunopharma, Inc. | 73.81M | 1.76% | 72,095 | - |
| 399 | IBO | Impact BioMedical Inc. | 72.88M | 2.05% | 56,125 | 32.00K |
| 400 | IBIO | iBio, Inc. | 72.54M | -4.11% | 685,420 | 300.00K |
| 401 | CUE | Cue Biopharma, Inc. | 70.74M | 65.37% | 66,306,273 | 27.47M |
| 402 | MNOV | MediciNova, Inc. | 70.39M | 1.42% | 21,106 | 409.66K |
| 403 | ATHE | Alterity Therapeutics Limited | 70.12M | 3.04% | 8,168 | 4.43M |
| 404 | BYSI | BeyondSpring Inc. | 69.49M | -2.31% | 2,408 | 1.88M |
| 405 | ICCC | ImmuCell Corporation | 68.76M | -1.68% | 30,971 | 27.64M |
| 406 | GRCE | Grace Therapeutics, Inc. | 67.47M | 1.87% | 1,087,139 | - |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 64.70M | 1.83% | 475,299 | - |
| 408 | TCRX | TScan Therapeutics, Inc. | 64.31M | 0.94% | 987,801 | 10.33M |
| 409 | INKT | MiNK Therapeutics, Inc. | 64.26M | -4.22% | 62,172 | - |
| 410 | HYFT | MindWalk Holdings Corp. | 63.57M | 8.47% | 336,777 | 20.70M |
| 411 | IMA | ImageneBio, Inc. | 63.20M | -1.40% | 207,860 | 800.00K |
| 412 | OKUR | OnKure Therapeutics, Inc. | 61.67M | -2.06% | 180,952 | - |
| 413 | ANVS | Annovis Bio, Inc. | 60.78M | 1.73% | 991,333 | - |
| 414 | CING | Cingulate Inc. | 60.47M | -2.80% | 469,897 | - |
| 415 | TIL | Instil Bio, Inc. | 60.29M | 5.33% | 81,896 | - |
| 416 | OSTX | OS Therapies Incorporated | 58.01M | -0.72% | 764,197 | - |
| 417 | DWTX | Dogwood Therapeutics, Inc. | 57.12M | -4.47% | 719,746 | - |
| 418 | ENTX | Entera Bio Ltd. | 55.01M | 4.42% | 67,603 | 42.00K |
| 419 | KZR | Kezar Life Sciences, Inc. | 54.40M | 0.27% | 139,927 | - |
| 420 | MGX | Metagenomi Therapeutics, Inc. | 54.17M | 0.70% | 143,285 | 25.21M |
| 421 | MREO | Mereo BioPharma Group plc | 54.08M | 2.98% | 4,881,595 | 500.00K |
| 422 | ACTU | Actuate Therapeutics, Inc. | 50.98M | 3.37% | 363,388 | - |
| 423 | RADX | Radiopharm Theranostics Limited | 50.78M | 1.09% | 11,407 | 10.86M |
| 424 | RNTX | Rein Therapeutics Inc. | 49.91M | 9.20% | 173,349 | - |
| 425 | NTRB | Nutriband Inc. | 49.60M | 0.49% | 6,171 | 2.28M |
| 426 | ATOS | Atossa Therapeutics, Inc. | 49.43M | 7.29% | 100,072 | - |
| 427 | XLO | Xilio Therapeutics, Inc. | 48.57M | -2.21% | 36,060 | 43.77M |
| 428 | EDSA | Edesa Biotech, Inc. | 47.63M | 2.68% | 130,353 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 46.07M | 2.29% | 41,756 | - |
| 430 | RNXT | RenovoRx, Inc. | 45.95M | -0.97% | 223,671 | 1.12M |
| 431 | ALGS | Aligos Therapeutics, Inc. | 45.91M | -15.10% | 181,731 | 2.19M |
| 432 | NXTC | NextCure, Inc. | 44.83M | -1.41% | 141,808 | - |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 44.69M | 0.23% | 87,850 | 1.14M |
| 434 | HYPD | Hyperion DeFi, Inc. | 43.97M | 8.43% | 269,079 | 813.46K |
| 435 | RLYB | Rallybio Corporation | 43.80M | 0.36% | 94,248 | 858.00K |
| 436 | LITS | Lite Strategy, Inc. | 43.63M | 4.35% | 91,504 | - |
| 437 | ATRA | Atara Biotherapeutics, Inc. | 42.85M | 1.75% | 53,634 | 120.77M |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 39.28M | 14.55% | 765,564 | 90.00K |
| 439 | SNSE | Sensei Biotherapeutics, Inc. | 39.15M | 1.78% | 57,167 | - |
| 440 | VERU | Veru Inc. | 39.00M | 0.41% | 18,400 | 16.89M |
| 441 | PSTV | Plus Therapeutics, Inc. | 38.77M | 4.05% | 477,936 | 5.21M |
| 442 | PASG | Passage Bio, Inc. | 38.14M | 9.48% | 51,878 | - |
| 443 | CRVO | CervoMed Inc. | 37.41M | - | 23,013 | 4.01M |
| 444 | PTN | Palatin Technologies, Inc. | 37.07M | 6.32% | 18,980 | 8.96M |
| 445 | BOLD | Boundless Bio, Inc. | 36.52M | 4.49% | 597,413 | - |
| 446 | LSTA | Lisata Therapeutics, Inc. | 36.22M | -11.48% | 256,598 | 170.00K |
| 447 | LIXT | Lixte Biotechnology Holdings, Inc. | 36.13M | 6.87% | 50,494 | - |
| 448 | CELU | Celularity Inc. | 36.05M | -3.85% | 5,835 | 40.58M |
| 449 | CVM | CEL-SCI Corporation | 35.45M | 0.46% | 37,805 | - |
| 450 | INMB | INmune Bio Inc. | 35.09M | 4.76% | 305,261 | 50.00K |
| 451 | PLUR | Pluri Inc. | 34.78M | 1.76% | 2,024 | 1.34M |
| 452 | EVAX | Evaxion A/S | 34.53M | - | 22,582 | 7.53M |
| 453 | BCTX | BriaCell Therapeutics Corp. | 33.41M | 1.76% | 129,167 | - |
| 454 | LGVN | Longeveron Inc. | 32.79M | - | 840,222 | 1.20M |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 32.55M | 9.81% | 97,658 | - |
| 456 | ABVC | ABVC BioPharma, Inc. | 32.37M | -3.68% | 89,748 | 797.92K |
| 457 | DYAI | Dyadic International, Inc. | 31.89M | 0.61% | 32,902 | 3.09M |
| 458 | IGC | IGC Pharma, Inc. | 30.66M | 3.19% | 255,533 | 1.11M |
| 459 | APLM | Apollomics, Inc. | 30.64M | -6.12% | 5,062 | 6.93M |
| 460 | TPST | Tempest Therapeutics, Inc. | 30.41M | -5.78% | 173,815 | - |
| 461 | JSPR | Jasper Therapeutics, Inc. | 29.40M | 12.61% | 499,585 | - |
| 462 | SNTI | Senti Biosciences, Inc. | 29.12M | 0.73% | 169,588 | 22.00K |
| 463 | KYNB | Kyntra Bio, Inc. | 28.81M | -3.39% | 8,915 | 6.44M |
| 464 | OTLK | Outlook Therapeutics, Inc. | 28.56M | 7.91% | 2,789,124 | 205.70K |
| 465 | CRIS | Curis, Inc. | 27.37M | 9.57% | 3,488,857 | 9.44M |
| 466 | LTRN | Lantern Pharma Inc. | 27.13M | 3.86% | 217,830 | - |
| 467 | TVGN | Tevogen Bio Holdings Inc. | 26.82M | 7.69% | 20,124 | - |
| 468 | MRKR | Marker Therapeutics, Inc. | 26.34M | -0.63% | 87,250 | 3.55M |
| 469 | DARE | Daré Bioscience, Inc. | 26.06M | 2.29% | 43,654 | 1.03M |
| 470 | NRSN | NeuroSense Therapeutics Ltd. | 25.81M | 2.82% | 109,357 | - |
| 471 | SKYE | Skye Bioscience, Inc. | 25.80M | -5.18% | 234,830 | - |
| 472 | LEXX | Lexaria Bioscience Corp. | 25.63M | 0.98% | 99,669 | 368.00K |
| 473 | NNVC | NanoViricides, Inc. | 25.27M | 12.50% | 259,434 | - |
| 474 | XCUR | Exicure, Inc. | 25.22M | 4.45% | 5,446 | 500.00K |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 25.07M | -1.27% | 20,401 | 14.99M |
| 476 | SER | Serina Therapeutics, Inc. | 25.00M | 5.18% | 81,204 | 130.00K |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 24.22M | 1.90% | 935,389 | 789.00K |
| 478 | BRNS | Barinthus Biotherapeutics plc | 24.22M | -1.33% | 11,435 | 14.97M |
| 479 | AEON | AEON Biopharma, Inc. | 23.93M | 6.40% | 1,120,290 | - |
| 480 | COCP | Cocrystal Pharma, Inc. | 20.68M | -1.96% | 319,710 | - |
| 481 | VYNE | VYNE Therapeutics Inc. | 20.66M | -0.48% | 59,644 | 570.00K |
| 482 | ALLR | Allarity Therapeutics, Inc. | 19.77M | 5.04% | 80,136 | 320.00K |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 19.15M | 3.88% | 318,107 | 3.94M |
| 484 | LPCN | Lipocine Inc. | 18.69M | 1.19% | 233,635 | 1.98M |
| 485 | KTTA | Pasithea Therapeutics Corp. | 18.60M | -5.58% | 1,067,754 | - |
| 486 | OSRH | OSR Holdings, Inc. | 18.11M | 4.71% | 493,311 | 2.91M |
| 487 | PLRZ | Polyrizon Ltd. | 18.07M | -1.50% | 32,956 | - |
| 488 | QNTM | Quantum BioPharma Ltd. | 17.61M | 1.66% | 208,278 | - |
| 489 | GNTA | Genenta Science S.p.A. | 16.83M | 11.28% | 70,262 | - |
| 490 | HIND | Vyome Holdings, Inc. | 15.72M | -1.75% | 16,050 | 319.71K |
| 491 | ICU | SeaStar Medical Holding Corporation | 15.42M | 2.93% | 73,633 | 1.23M |
| 492 | PHIO | Phio Pharmaceuticals Corp. | 15.33M | 2.33% | 137,078 | - |
| 493 | JUNS | Jupiter Neurosciences, Inc. | 14.45M | 1.22% | 52,052 | 21.80K |
| 494 | INAB | IN8bio, Inc. | 13.79M | 1.45% | 60,002 | - |
| 495 | INTS | Intensity Therapeutics, Inc. | 13.46M | -1.12% | 24,300 | - |
| 496 | HOTH | Hoth Therapeutics, Inc. | 13.33M | 7.93% | 7,575,118 | - |
| 497 | MBRX | Moleculin Biotech, Inc. | 13.02M | -2.01% | 132,893 | - |
| 498 | BCDA | BioCardia, Inc. | 13.02M | 0.85% | 19,947 | 3.00K |
| 499 | CLRB | Cellectar Biosciences, Inc. | 12.89M | 3.05% | 25,978 | - |
| 500 | KAPA | Kairos Pharma, Ltd. | 12.85M | 0.08% | 67,699 | - |